Formica and colleagues found that in 31 metastatic CRC participants, neutrophil TLR4 expression at baseline, or 1-month post-chemotherapy, had no association with PFS (P > 0.05) (Formica et al. 2013). The gene discussed is TLR4; the disease is colorectal carcinoma.